Skip to main content
. 2018;19(10):2991–2999. doi: 10.22034/APJCP.2018.19.10.2991

Figure 7.

Figure 7

Methylation Detection of RASSF1A and RB via MSP. A, Colon cancer cells (CaCo-2) treated with elevated doses of MET and subjected to MSP to detect RB prompter methylation; B, Colon cancer cells (CaCo-2) treated with elevated doses of MET and subjected to MSP to detect RASSF1A prompter methylation; C, Breast cancer cells (MCF-7) treated with elevated doses of MET and subjected to MSP to detect RB prompter methylation; D, Breast cancer cells (MCF-7) treated with elevated doses of MET and subjected to MSP to detect RASSF1A prompter methylation.

HHS Vulnerability Disclosure